USD 1.56
(-0.64%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -27.32 Million USD | 29.11% |
2022 | -37.9 Million USD | -41.2% |
2021 | -26.84 Million USD | 1.04% |
2020 | -27.12 Million USD | 37.17% |
2019 | -43.16 Million USD | -34.49% |
2018 | -32.09 Million USD | -161.51% |
2017 | -12.27 Million USD | 4.45% |
2016 | -12.84 Million USD | 10.68% |
2015 | -14.38 Million USD | 6.26% |
2014 | -15.34 Million USD | 4.54% |
2013 | -16.07 Million USD | -36.43% |
2012 | -11.77 Million USD | -28.06% |
2011 | -9.19 Million USD | 17.33% |
2010 | -11.12 Million USD | 47.28% |
2009 | -21.1 Million USD | -33.86% |
2008 | -15.76 Million USD | 1.43% |
2007 | -15.99 Million USD | -54.55% |
2006 | -10.34 Million USD | -101.44% |
2005 | -5.13 Million USD | 27.83% |
2004 | -7.11 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -6.61 Million USD | -1.75% |
2024 Q2 | -7.21 Million USD | -12.17% |
2023 Q1 | -8.71 Million USD | 2.57% |
2023 Q4 | -6.49 Million USD | -42.49% |
2023 FY | -26.86 Million USD | 29.11% |
2023 Q2 | -7.74 Million USD | 11.17% |
2023 Q3 | -4.56 Million USD | 41.1% |
2022 Q2 | -9.17 Million USD | -16.8% |
2022 FY | -37.9 Million USD | -41.2% |
2022 Q3 | -11.93 Million USD | -30.08% |
2022 Q4 | -8.94 Million USD | 25.0% |
2022 Q1 | -7.85 Million USD | -8.35% |
2021 Q3 | -7.15 Million USD | -7.0% |
2021 Q4 | -7.24 Million USD | -1.34% |
2021 FY | -26.84 Million USD | 1.04% |
2021 Q1 | -5.76 Million USD | 16.9% |
2021 Q2 | -6.68 Million USD | -16.02% |
2020 Q2 | -6.49 Million USD | 0.0% |
2020 FY | -27.12 Million USD | 37.17% |
2020 Q1 | -6.49 Million USD | 43.56% |
2020 Q4 | -6.93 Million USD | 0.0% |
2020 Q3 | -6.93 Million USD | -6.73% |
2019 Q4 | -11.5 Million USD | 0.0% |
2019 FY | -43.16 Million USD | -34.49% |
2019 Q1 | -6.93 Million USD | 19.15% |
2019 Q2 | -6.93 Million USD | 0.0% |
2019 Q3 | -11.5 Million USD | -66.01% |
2018 Q4 | -8.57 Million USD | 0.0% |
2018 FY | -32.09 Million USD | -161.51% |
2018 Q1 | -7.47 Million USD | -16.58% |
2018 Q2 | -7.47 Million USD | 0.0% |
2018 Q3 | -8.57 Million USD | -14.67% |
2017 Q3 | -6.41 Million USD | -2423.55% |
2017 Q2 | 276 Thousand USD | 0.0% |
2017 Q4 | -6.41 Million USD | 0.0% |
2017 Q1 | 276 Thousand USD | 110.38% |
2017 FY | -12.27 Million USD | 4.45% |
2016 Q4 | -2.65 Million USD | 0.0% |
2016 Q1 | -3.76 Million USD | 15.48% |
2016 Q3 | -2.65 Million USD | 29.36% |
2016 Q2 | -3.76 Million USD | 0.0% |
2016 FY | -12.84 Million USD | 10.68% |
2015 Q1 | -2.73 Million USD | 24.56% |
2015 Q3 | -4.45 Million USD | -62.68% |
2015 Q4 | -4.45 Million USD | 0.0% |
2015 FY | -14.38 Million USD | 6.26% |
2015 Q2 | -2.73 Million USD | 0.0% |
2014 Q2 | -4.04 Million USD | 0.0% |
2014 FY | -15.34 Million USD | 4.54% |
2014 Q4 | -3.62 Million USD | 0.0% |
2014 Q3 | -3.62 Million USD | 10.25% |
2014 Q1 | -4.04 Million USD | 1.28% |
2013 Q2 | -3.91 Million USD | 0.0% |
2013 FY | -16.07 Million USD | -36.43% |
2013 Q1 | -3.91 Million USD | -33.71% |
2013 Q3 | -4.09 Million USD | -4.74% |
2013 Q4 | -4.09 Million USD | 0.0% |
2012 Q2 | -2.87 Million USD | 0.0% |
2012 Q1 | -2.87 Million USD | -25.17% |
2012 Q3 | -2.99 Million USD | -4.12% |
2012 Q4 | -2.92 Million USD | 2.43% |
2012 FY | -11.77 Million USD | -28.06% |
2011 Q1 | -2.29 Million USD | 17.33% |
2011 Q4 | -2.29 Million USD | 0.0% |
2011 FY | -9.19 Million USD | 17.33% |
2011 Q2 | -2.29 Million USD | 0.0% |
2011 Q3 | -2.29 Million USD | 0.0% |
2010 Q4 | -2.78 Million USD | 0.0% |
2010 Q2 | -2.78 Million USD | 0.0% |
2010 Q3 | -2.78 Million USD | 0.0% |
2010 Q1 | -2.78 Million USD | 47.28% |
2010 FY | -11.12 Million USD | 47.28% |
2009 Q1 | -5.27 Million USD | -33.86% |
2009 Q3 | -5.27 Million USD | 0.0% |
2009 FY | -21.1 Million USD | -33.86% |
2009 Q4 | -5.27 Million USD | 0.0% |
2009 Q2 | -5.27 Million USD | 0.0% |
2008 Q2 | -3.94 Million USD | 0.0% |
2008 Q4 | -3.94 Million USD | 0.0% |
2008 Q1 | -3.94 Million USD | 1.82% |
2008 Q3 | -3.94 Million USD | 0.0% |
2008 FY | -15.76 Million USD | 1.43% |
2007 Q3 | -4.01 Million USD | 0.0% |
2007 FY | -15.99 Million USD | -54.55% |
2007 Q4 | -4.01 Million USD | 0.0% |
2007 Q1 | -4.01 Million USD | -51.61% |
2007 Q2 | -4.01 Million USD | 0.0% |
2006 Q3 | -2.64 Million USD | 0.0% |
2006 Q2 | -2.64 Million USD | 0.0% |
2006 Q1 | -2.64 Million USD | -103.31% |
2006 FY | -10.34 Million USD | -101.44% |
2006 Q4 | -2.64 Million USD | 0.0% |
2005 FY | -5.13 Million USD | 27.83% |
2005 Q2 | -1.3 Million USD | 0.0% |
2005 Q3 | -1.3 Million USD | 0.0% |
2005 Q1 | -1.3 Million USD | 27.51% |
2005 Q4 | -1.3 Million USD | 0.0% |
2004 Q4 | -1.79 Million USD | 0.0% |
2004 Q2 | -1.79 Million USD | 0.0% |
2004 Q3 | -1.79 Million USD | 0.0% |
2004 Q1 | -1.79 Million USD | 0.0% |
2004 FY | -7.11 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aspira Women's Health Inc. | -18.85 Million USD | -44.955% |
bioAffinity Technologies, Inc. | -7.97 Million USD | -242.734% |
Intelligent Bio Solutions Inc. | -10.28 Million USD | -165.745% |
Standard BioTools Inc. | -76.6 Million USD | 64.325% |
Inotiv, Inc. | -81.46 Million USD | 66.453% |
Prenetics Global Limited | -52.51 Million USD | 47.962% |
Neuronetics, Inc. | -30.55 Million USD | 10.562% |
Star Equity Holdings, Inc. | -4.34 Million USD | -528.785% |
Castle Biosciences, Inc. | -67.97 Million USD | 59.8% |
Psychemedics Corporation | -2.92 Million USD | -835.536% |
RadNet, Inc. | 98.69 Million USD | 127.688% |
Exact Sciences Corporation | -215.01 Million USD | 87.29% |
IDEXX Laboratories, Inc. | 1.09 Billion USD | 102.491% |
iSpecimen Inc. | -11.16 Million USD | -144.661% |
OpGen, Inc. | -15.68 Million USD | -74.185% |
Exagen Inc. | -22.83 Million USD | -19.661% |
Bionano Genomics, Inc. | -215.24 Million USD | 87.304% |
CareDx, Inc | -101.9 Million USD | 73.183% |
Check-Cap Ltd. | -19.28 Million USD | -41.686% |
Twist Bioscience Corporation | -220.83 Million USD | 87.625% |
Guardant Health, Inc. | -564.72 Million USD | 95.161% |
Biodesix, Inc. | -41.34 Million USD | 33.9% |
BioNexus Gene Lab Corp. | -2.59 Million USD | -953.637% |
Precipio, Inc. | -7.62 Million USD | -258.622% |
Natera, Inc. | -446.24 Million USD | 93.876% |
Fulgent Genetics, Inc. | -72.69 Million USD | 62.409% |
Sera Prognostics, Inc. | -39.82 Million USD | 31.375% |
23andMe Holding Co. | -321.35 Million USD | 91.496% |
OPKO Health, Inc. | -157.02 Million USD | 82.597% |
Personalis, Inc. | -109.93 Million USD | 75.143% |
Aclaris Therapeutics, Inc. | -97.35 Million USD | 71.931% |
Applied DNA Sciences, Inc. | -10.95 Million USD | -149.487% |
T2 Biosystems, Inc. | -49.66 Million USD | 44.976% |
Neogen Corporation | 58.66 Million USD | 146.583% |
Myriad Genetics, Inc. | -123.7 Million USD | 77.909% |
ICON Public Limited Company | 956.15 Million USD | 102.858% |
NeoGenomics, Inc. | -107.73 Million USD | 74.635% |
Star Equity Holdings, Inc. | -4.34 Million USD | -528.785% |
Prenetics Global Limited | -52.51 Million USD | 47.962% |
Illumina, Inc. | -1.06 Billion USD | 97.444% |
DarioHealth Corp. | -56.18 Million USD | 51.366% |
ENDRA Life Sciences Inc. | -10.52 Million USD | -159.744% |
Medpace Holdings, Inc. | 336.82 Million USD | 108.113% |
Mainz Biomed B.V. | -26.64 Million USD | -2.561% |
Trinity Biotech plc | -27.04 Million USD | -1.043% |
Sotera Health Company | 276.69 Million USD | 109.876% |
bioAffinity Technologies, Inc. | -7.97 Million USD | -242.734% |